Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ther Drug Monit ; 33(2): 185-91, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21383649

RESUMEN

Pharmacodynamic drug monitoring might allow an improved use of immunosuppressive medication in transplant recipients. We assessed whether drug concentrations reflect the effect of cyclosporine (CsA) on expression of nuclear factor of activated T-cells-regulated cytokines. CsA drug concentrations and expression of interleukin-2, interferon-γ, and granulocyte-macrophage colony-stimulating factor in stimulated blood lymphocytes were determined predose (C0) and 2 hours after (C2) CsA intake in 20 de novo (less than 3 months) and 20 long-term (3 months to 10 years) liver transplant patients. The residual cytokine expression at C2 relative to C0 was calculated. Mean CsA C0 and C2 concentrations were 236 and 776 µg/L in de novo and 100 and 573 µg/L in long-term liver transplant patients, respectively. Two hours after CsA intake, the residual cytokine expression for all cytokines was comparable in both groups (de novo patients mean 16%; long-term patients mean 17%). CsA C2 concentrations showed a significant (P < 0.01) correlation with the residual cytokine expression of interleukin-2, interferon-γ, and granulocyte-macrophage colony-stimulating factor in both de novo and long-term patients, whereas CsA C0 concentrations did not. The data suggest that CsA C2 concentrations, but not C0 concentrations, reflect the effect of CsA on downregulation of cytokine expression in both de novo and long-term liver transplant patients.


Asunto(s)
Ciclosporina/sangre , Ciclosporina/uso terapéutico , Monitoreo de Drogas , Inmunosupresores/uso terapéutico , Trasplante de Hígado , Factores de Transcripción NFATC/sangre , Factores de Transcripción NFATC/genética , Ciclosporina/administración & dosificación , Ciclosporina/metabolismo , Expresión Génica , Factor Estimulante de Colonias de Granulocitos y Macrófagos/biosíntesis , Factor Estimulante de Colonias de Granulocitos y Macrófagos/sangre , Humanos , Inmunosupresores/administración & dosificación , Inmunosupresores/sangre , Inmunosupresores/metabolismo , Interferón gamma/biosíntesis , Interferón gamma/sangre , Interleucina-2/biosíntesis , Interleucina-2/sangre , Linfocitos/metabolismo , Linfocitos T/metabolismo , Factores de Tiempo
2.
BMC Gastroenterol ; 6: 36, 2006 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-17121681

RESUMEN

BACKGROUND: Gallstones represent a prevalent and costly health problem. The changing epidemiology and the emerging non-surgical interventions for gallstone disease necessitate the definition of target populations for future therapies. This study aimed to define patterns of gallstone composition and identify demographic predictors of gallstone composition in a large sample of symptomatic gallstones from Northern Germany. METHODS: One thousand and seventy-four post-cholecystectomy gallstone specimens were obtained. Demographic and clinical information was provided by questionnaire (N = 1025 independent individuals with complete information). Two samples from each gallstone were analyzed using Fourier transformed infrared spectrometry. RESULTS: The most prevalent substance was cholesterol, which was detected in 95.0% of gallstone specimens. Bilirubin and bilirubinate were present in 30.0% and calcium was detected in 10.0% of the spectra. Ninety-two percent of measurements from the same stone yielded the same "main" substances, indicating a homogenous stone composition in most cases. Female sex and higher body mass index (BMI) were associated with the presence of cholesterol as a main substance in the gallstones (p < 0.001). CONCLUSION: The changing epidemiology of gallstone disease is reflected by a marked shift in stone composition: Only two percent of stones in this study were pigment stones as compared to 91% percent of stones containing cholesterol as a main substance. Obese individuals from Germany with a BMI > 30 kg/m2 have in 95% cholesterol-dominant gallstones and represent a potential target population for non-surgical interventions for the prevention or treatment of cholesterol stones.


Asunto(s)
Cálculos Biliares/química , Factores de Edad , Pigmentos Biliares/análisis , Bilirrubina/análisis , Índice de Masa Corporal , Calcio/análisis , Colecistectomía , Colesterol/análisis , Femenino , Cálculos Biliares/clasificación , Cálculos Biliares/epidemiología , Cálculos Biliares/patología , Alemania/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Distribución por Sexo , Factores Sexuales , Espectroscopía Infrarroja por Transformada de Fourier
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...